Department of Oral Health Sciences, University of Washington School of Dentistry, Seattle, WA.
Med Care. 2021 May 1;59(5):386-392. doi: 10.1097/MLR.0000000000001504.
Opioids are generally an inappropriate acute pain management strategy in children, particularly because of the risk for diversion and subsequent misuse and abuse.
To examine associations between Medicaid plan type [coordinated care organization (CCO), managed care (MC), fee-for-service (FFS)] and whether a child received an opioid prescription.
Secondary analysis of Oregon Medicaid data (January 1, 2016 to December 31, 2017).
Medicaid-enrolled children ages 0-17 (N=200,169).
There were 2 outcomes: whether a child received an opioid prescription from (a) any health provider or (b) from a visit to the dentist. Predictor variables included Medicaid plan type, age, sex, race, and ethnicity.
About 6.7% of children received an opioid from any health provider and 1.2% received an opioid from a dentist visit. Children in a CCO were significantly more likely than children in a MC (P<0.01) or FFS (P=0.02) plan to receive an opioid from any health provider. Children in a CCO were also significantly more likely than children in MC or FFS to receive an opioid from a dentist visit (P<0.01).
Pediatric opioid prescriptions vary by plan type. Future efforts should identify reasons why Medicaid-enrolled children in a CCO plan are more likely to be prescribed opioids.
阿片类药物通常不适合用于儿童的急性疼痛管理,特别是因为存在滥用和误用的风险。
研究医疗补助计划类型(综合护理组织(CCO)、管理式医疗(MC)、按服务收费(FFS))与儿童是否接受阿片类药物处方之间的关联。
俄勒冈州医疗补助数据的二次分析(2016 年 1 月 1 日至 2017 年 12 月 31 日)。
医疗补助计划覆盖的 0-17 岁儿童(N=200169)。
有两个结果:(a)儿童是否从任何医疗服务提供者处获得阿片类药物处方,(b)儿童是否从看牙医的就诊中获得阿片类药物处方。预测变量包括医疗补助计划类型、年龄、性别、种族和民族。
约 6.7%的儿童从任何医疗服务提供者处获得阿片类药物处方,1.2%的儿童从看牙医的就诊中获得阿片类药物处方。与 MC 或 FFS 计划相比,CCO 中的儿童从任何医疗服务提供者处获得阿片类药物处方的可能性显著更高(P<0.01)。与 MC 或 FFS 相比,CCO 中的儿童从牙医处获得阿片类药物处方的可能性也显著更高(P<0.01)。
儿科阿片类药物处方因计划类型而异。未来的工作应确定为什么 CCO 计划中医疗补助计划覆盖的儿童更有可能被开具阿片类药物处方的原因。